August 2022
1. JALAL PK
   Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat?
   Cancer. 2022 Aug 9. doi: 10.1002/cncr.34408.
   

   >> Share

   
   July 2022
2. PARIKH ND, Mehta N, Hoteit MA, Yang JD, et al
   Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
   Cancer. 2022 Jul 7. doi: 10.1002/cncr.34378.
   

   >> Share

   
   May 2022
3. SHORT SS, Kastenberg ZJ, Wei G, Bondoc A, et al
   Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
   Cancer. 2022 May 13. doi: 10.1002/cncr.34256.
   

   >> Share

   
   April 2022
4. DE B, Tran Cao HS, Vauthey JN, Manzar GS, et al
   Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.
   Cancer. 2022 Apr 13. doi: 10.1002/cncr.34223.
   

   >> Share

   
   March 2022
5. LEBECK LEE CM, Ziogas IA, Agarwal R, Alexopoulos SP, et al
   A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
   Cancer. 2022 Mar 14. doi: 10.1002/cncr.34170.
   

   >> Share

   
   
6. ROBERTS HJ, Wo JY
   Stereotactic body radiation therapy for primary liver tumors: An effective liver-directed therapy in the toolbox.
   Cancer. 2022;128:956-965.
   

   >> Share

   
   January 2022
7. NIERENGARTEN MB
   Aspirin decreases the risk of hepatocellular cancer in at-risk patients.
   Cancer. 2022;128:214-215.
   

   >> Share

   
   November 2021
8. KATZENSTEIN HM, Malogolowkin MH, Krailo MD, Piao J, et al
   Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
   Cancer. 2021 Nov 11. doi: 10.1002/cncr.34014.
   

   >> Share

   
   October 2021
9. DUONG LM, Cai H, Shrubsole MJ, Bailey CE, et al
   Outcomes of robotic-assisted liver surgery versus laparoscopic liver surgery for treatment of stage I hepatocellular carcinoma.
   Cancer. 2021 Oct 21. doi: 10.1002/cncr.33979.
   

   >> Share

   
   
10. CHENG K, Chen Y, Wang X, Xu M, et al
    Entecavir combined with interferon-alpha is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B.
    Cancer. 2021 Oct 8. doi: 10.1002/cncr.33949.
    

    >> Share

    
    August 2021
11. HARDING JJ, Yang TS, Chen YY, Feng YH, et al
    Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study.
    Cancer. 2021 Aug 20. doi: 10.1002/cncr.33870.
    

    >> Share

    
    July 2021
12. MERRIAM P, Nathenson MJ
    Liver transplantation for hepatic epithelioid hemangioendothelioma.
    Cancer. 2021 Jul 13. doi: 10.1002/cncr.33751.
    

    >> Share

    
    
13. DING X, Sun W, Li W, Shen Y, et al
    Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33677.
    

    >> Share

    
    February 2021
14. SHALTIEL T, Zheng S, Siderides C, Gleeson EM, et al
    Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33377.
    

    >> Share

    
    
15. HOEHN RS
    Racial disparities in hepatocellular carcinoma.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33376.
    

    >> Share

    
    November 2020
16. RYOO BY, Merle P, Kulkarni AS, Cheng AL, et al
    Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
    Cancer. 2020 Nov 24. doi: 10.1002/cncr.33317.
    

    >> Share

    
    
17. DI GIUSEPPE G, Youlden DR, Aitken JF, Pole JD, et al
    Pediatric hepatic cancer incidence and survival: 30-year trends in Ontario, Canada; the United States; and Australia.
    Cancer. 2020 Nov 16. doi: 10.1002/cncr.33319.
    

    >> Share

    
    October 2020
18. WONG RJ, Kim D, Ahmed A, Singal AK, et al
    Patients with hepatocellular carcinoma from more rural and lower income households have more advanced tumor stage at diagnosis and significantly higher mortality.
    Cancer. 2020 Oct 26. doi: 10.1002/cncr.33211.
    

    >> Share

    
    April 2020
19. FIALA EM, Ortiz MV, Kennedy JA, Glodzik D, et al
    11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
    Cancer. 2020 Apr 22. doi: 10.1002/cncr.32907.
    

    >> Share

    
    March 2020
20. KOBAYASHI H, Iwata S, Wakamatsu T, Hayakawa K, et al
    Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study.
    Cancer. 2020;126:1253-1263.
    

    >> Share

    
    January 2020
21. UPPAL A, Smieliauskas F, Sharma MR, Maron SB, et al
    Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases.
    Cancer. 2020;126:281-292.
    

    >> Share

    
    March 2019
22. KANTARJIAN HM, DeAngelo DJ, Stelljes M, Liedtke M, et al
    Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
    Cancer. 2019 Mar 28. doi: 10.1002/cncr.32116.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share